Fundamental dimension Equity attribute | CLBTLeader $12.10▲+2.63% Cap $3.04BP/E 51.4x QuantScore66/100 | AWREPeer $0.8646▼-0.67% Cap $18.86MP/E -2.2x QuantScore34/100 | AXONPeer $420.37▲+1.39% Cap $34.15BP/E 169.4x QuantScore55/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
73/100 |
23/100 |
60/100 |
Valuation Multiples, PEG & DCF upside | 48/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 49/100 | 62/100 |
Growth Revenue / earnings growth & margins | 76/100 | 30/100 | 73/100 |
Sentiment Analyst ratings, targets & revisions | 68/100 | — | 79/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 51.4x | -2.2x | 169.4x |
Forward P/E (next FY) | 43.9x | — | 54.7x |
EV / EBITDA (TTM) | 25.7x | -2.6x | 74.1x |
Price / Sales | 5.9x | 1.1x | 10.6x |
Price / Free Cash Flow | 21.8x | -2.7x | 256.4x |
PEG ratio | 0.59 | 0.06 | -4.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 2 / 9 | 5 / 9 |
Altman Z-Score | 4.99 (Safe) | -2.35 (Distress) | 6.44 (Safe) |
Total debt / equity | 0.04 | 0.18 | 0.50 |
Quick ratio | 1.6x | 3.7x | 1.8x |
Interest coverage | — | — | 0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +18.6% | -0.6% | +33.5% |
Net income growth YoY | +127.7% | -32.5% | -66.9% |
Gross margin (TTM) | 83.0% | 90.3% | 59.4% |
Operating margin (FY) | 14.0% | -37.9% | -2.2% |
FCF margin (FY) | 32.7% | -32.2% | 2.7% |
5. Trailing price performancePrice change over period |
1M return | +12.1% | -23.5% | -5.5% |
3M return | -14.9% | -20.7% | -16.3% |
6M return | -4.7% | -36.0% | +5.9% |
Year to date | -32.9% | -53.3% | -26.0% |
1Y return | -34.6% | -65.4% | -42.9% |
3Y return | +77.9% | -25.5% | +97.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.8995 -107.4% premium | $-1.67 -292.6% premium | $-78.52 -118.7% premium |
Wall Street consensus target | $14.13 +16.8% · range $12.50–$15.00 | — — | $633.63 +50.7% · range $440.00–$750.00 |
Consensus stance | 100% Buy0% Hold0% Sell | — | 82% Buy18% Hold-0% Sell |